Journal: Acta Pharmaceutica Sinica. B
Article Title: Macrophage DGK ζ -mediated phosphatidic acid remodeling aggravates acute liver failure
doi: 10.1016/j.apsb.2025.06.019
Figure Lengend Snippet: DGK ζ plays a critical role in macrophage-mediated inflammation and liver failure. (A) The protein level of DGK ζ in LPS-stimulated RAW264.7 cells was determined by Western blotting. (B–D) Stable shNC- and sh Dgkz -RAW264.7 cells were stimulated with LPS. The level of PA (B) and IL-1 β expression (C, D) were measured by a commercial kit, Q-PCR, and Western blotting, respectively. (E) PMA-differentiated THP-1 cells were transfected with siNC or si DGKZ , followed by LPS stimulation for 4 h. The IL-1 β expression was detected by Q-PCR and Western blotting. (F–H) BMDMs from wild-type (WT) and Dgkz −/− mice were stimulated with LPS + ATP. The culture medium (CM) was collected for examination of IL-1 β concentration (F) by HTRF, and added to the primary hepatocytes along with D-GalN. The levels of cleaved-PARP (c-PARP) and cleaved-Caspase 3 (c-Caspase 3) (G), and the activity of Caspase 3 (scar bar: 100 μm) (H) were determined. (I, J) ALF was induced in mice by LPS + D-GalN. After 1.5, 3 and 4 h, the protein level of DGK ζ in the liver was determined by Western blotting (I). After 6 h, the protein levels of DGK ζ in F4/80 + and Ly6G + cells sorted from the liver were determined by Western blotting (J). (K) Hepatic DGK ζ + CD68 + cells in Healthy Controls ( n = 6) and ACLF patients ( n = 5) were marked (scar bar: 50 μm) and counted. (L–N) WT and Dgkz −/− mice were administered with LPS + D-GalN for 6 h. The liver index (L), the levels of ALT, AST and LDH in plasma (M), the histological alterations of the liver (scar bar: 50 μm) (N), the frequency of MoMFs in liver (O), the mRNA level of Il1b in liver (P), and the IL-1 β concentration in plasma (Q) were evaluated. Data are displayed as mean ± SEM (For A–H, n = 3; For I, J, I–N, n = 6). ∗ P < 0.05, ∗∗ P < 0.01 vs . the indicated group.
Article Snippet: Primary antibodies applied included DGK ζ (1:1000; ab239080) which was obtained from Abcam (Cambridge, UK), proline rich tyrosine kinase 2 (Pyk2) (1:3000; 17592-1-AP), DGK α (1:2000; 11547-1-AP), DGK ε (1:1000; 11900-1-AP), DGK θ (1:500; 17885-1-AP) and β -Actin (1:8000; 66009-1-Ig) which were obtained from Proteintech (Wuhan, China), DGK γ (1:500; DF13919) which was obtained from Affinity (Cincinnati, USA), DGK δ (1:500; A15115) and α -Tubulin (1:1000; A6830) which were obtained from Ablconal, IL-1 β (1:1000; 12242), poly-ADP-ribose-polymerase (PARP) (1:1000; 9542), Caspase 3 (1:1000; 9662), p65 (1:1000; 8242), pp65 (1:1000; 3033), STAT3 (1:1000; 9139), pSTAT3 Ser727 (1:1000; 9134), pSTAT3 Tyr705 (1:2000; 9145), and pPyk2 (1:1000; 3291) which were obtained from Cell Signaling Technology (Danvers, USA), janus kinase 2 (JAK2) (1:1000; AF1489) and pJAK2 (1:500; AF5854) which were obtained from Beyotime, suppressor of cytokine signaling-1 (SOCS1) (1:500; WL05128) and SOCS3 (1:1000; WL01364) which were obtained from Wanleibio (Shenyang, China).
Techniques: Western Blot, Expressing, Transfection, Concentration Assay, Activity Assay, Clinical Proteomics